1. Composition of the neutralising antibody response predicts risk of BK virus DNAaemia in recipients of kidney transplantsResearch in context
- Author
-
Stephanie M.Y. Chong, Rachel K.Y. Hung, Fernando Yuen Chang, Claire Atkinson, Raymond Fernando, Mark Harber, Ciara N. Magee, Alan D. Salama, and Matthew Reeves
- Subjects
Post-transplant infections ,BK virus ,Kidney transplantation ,BKV serotyping ,Medicine ,Medicine (General) ,R5-920 - Abstract
Summary: Background: BK polyomavirus (BKV) DNAaemia occurs in 10% of recipients of kidney transplants, contributing to premature allograft failure. Evidence suggests disease is donor derived. Hypothetically, recipient infection with a different BKV serotype increases risk due to poorer immunological control. Thus, understanding the composition and activity of the humoral anti-BKV responses in donor/recipient (D/R) pairs is critical. Methods: Using 224 paired pre-transplant D/R samples, BKV VP1 genotype-specific pseudoviruses were employed to define the breadth of the antibody response against different serotypes (ELISA) and, to characterise specific neutralising activity (nAb) using the 50% inhibitory concentration (LogIC50). Mismatch (MM) ratios were calculated using the ratio of recipient ELISA or nAb reactive BKV serotypes relative to the number of donor reactive serotypes. Findings: BKV DNAaemia was observed in 28/224 recipients of kidney transplants. These recipients had lower nAb titres against all the serotypes, with median logIC50 values of 1.19–2.91, compared to non-viraemic recipients’ median logIC50 values of 2.13–3.30. nAb D/R MM ratios >0.67 associated with significantly higher risk of BKV viraemia, with an adjusted odds ratio of 5.12 (95% CI 2.07 to 13.04; p
- Published
- 2024
- Full Text
- View/download PDF